RecallHawk

CETIRIZINE HYDROCHLORIDE AND PSEUDOEPHEDRINE HYDROCHLORIDE

AUROBINDO PHARMA LTD

Summary

FDA approved CETIRIZINE HYDROCHLORIDE AND PSEUDOEPHEDRINE HYDROCHLORIDE by AUROBINDO PHARMA LTD. ANDA (Generic) approval on 2023-03-08. TABLET, EXTENDED RELEASE, ORAL.

Details

Source

Drug Approval

External ID

ANDA212409-1

Action Date

2023-03-08

Status

Approved

Category

drug

Product Code

ANDA (Generic)

Product Description

CETIRIZINE HYDROCHLORIDE AND PSEUDOEPHEDRINE HYDROCHLORIDE, TABLET, EXTENDED RELEASE, ORAL. Application: ANDA212409

Context & Analysis

AUROBINDO PHARMA LTD has 77 FDA actions in our database.

Frequently Asked Questions

How often does AUROBINDO PHARMA LTD have FDA actions?

AUROBINDO PHARMA LTD has 77 FDA actions in our database, including 0 recalls and 0 device clearances.

Where can I find the official FDA record?

The official record is available on FDA.gov. Search for "ANDA212409-1" on FDA.gov for the full record. You can also use the openFDA API to query this record programmatically.

Want to know the moment something like this happens?

Get alerts for drug

Related Actions